Soligenix Announces Positive Clinical Results for HyBryte™ in CTCL Treatment
25 Jun 2024 //
PR NEWSWIRE
Helsinn signs exclusive license deal with Juniper Biologics
01 Sep 2022 //
THEPHARMALETTER
Helsinn Healthcare SA signs exclusive license agreement with Juniper for LEDAGA®
01 Sep 2022 //
GLOBENEWSWIRE
Recordati & Helsinn Agreement For Commercialization Rights To Ledaga®
18 Dec 2018 //
GLOBENEWSWIRE
Actelion Registration Ledaga (Chlormethine) Receives Approval In Europe
16 Mar 2017 //
EMA